의료 기록 및 공급망 무결성용 블록체인 시장 예측(-2034년) : 구성요소, 블록체인 종류, 도입 모델, 용도, 최종사용자, 지역별 세계 분석

According to Stratistics MRC, the Global Blockchain for Medical Records & Supply Chain Integrity Market is accounted for $8.3 billion in 2026 and is expected to reach $216.6 billion by 2034 growing at a CAGR of 50.4% during the forecast period. Blockchain for Medical Records & Supply Chain Integrity involves applying distributed ledger technology to protect healthcare data and enhance transparency in medical product distribution. It allows healthcare providers to maintain reliable digital records, control information access, and reduce unauthorized data alterations. Within supply chains, blockchain supports tracking medicines and medical equipment, validating product origins, monitoring transactions, and identifying potential counterfeit products. These capabilities improve information reliability, strengthen coordination among stakeholders, and promote greater traceability, security, and accountability throughout healthcare operations.

According to the U.S. Office of the National Coordinator for Health Information Technology (ONC), 70% of non-federal acute care hospitals in the United States engaged in all four domains of electronic health information exchange (sending, finding, receiving, and integrating information) either routinely or sometimes in 2023.

Market Dynamics:

Driver:

Increasing demand for secure and interoperable healthcare data management

Rising demand for protected and accessible medical information is supporting the adoption of blockchain across healthcare systems. Hospitals and other medical institutions manage confidential patient records that require strong security and dependable information-sharing mechanisms. Blockchain offers distributed storage, encrypted transactions, and records that are difficult to alter without authorization. These capabilities help improve data reliability while supporting secure communication between healthcare providers, diagnostic laboratories, insurance companies, and other stakeholders, increasing interest in blockchain-enabled medical record management platforms.

Restraint:

High implementation costs and complex integration with existing healthcare

The significant investment required for blockchain deployment and compatibility with existing healthcare infrastructure limits market expansion. Many hospitals and medical institutions rely on established digital systems that may require considerable upgrades before blockchain integration. Expenses associated with platform development, cybersecurity, infrastructure maintenance, and workforce training can create financial pressure. Smaller healthcare facilities may struggle to allocate sufficient resources for adoption. Furthermore, connecting blockchain applications with electronic medical records and supply chain platforms involves technical complexities that can delay implementation across healthcare organizations.

Opportunity:

Integration of blockchain with artificial intelligence and healthcare data

Combining blockchain technology with artificial intelligence and healthcare analytics creates new growth opportunities in digital healthcare management. Blockchain offers protected and verifiable information records, while artificial intelligence helps process medical data to generate useful insights and improve operational decisions. Their integration can support advanced medical information systems, secure data sharing, and more efficient healthcare administration. Increasing interest in intelligent healthcare platforms may encourage technology developers and medical institutions to introduce integrated solutions that strengthen information reliability and support data-based healthcare services.

Threat:

Cybersecurity vulnerabilities and potential blockchain network attacks

The possibility of cyberattacks and security weaknesses presents challenges for blockchain adoption across healthcare information and supply chain systems. While distributed ledgers protect recorded transactions, associated software, user credentials, connected devices, and network components can still face security risks. Stolen access keys, defective smart contracts, and unauthorized system activities may expose confidential medical records or disrupt product tracking. These threats can affect organizational trust, increase operational expenses, and encourage healthcare institutions to invest in stronger cybersecurity infrastructure and regular system assessments.

Covid-19 Impact:

The COVID-19 outbreak increased attention toward blockchain applications in healthcare by demonstrating the need for reliable medical data protection and efficient supply chain monitoring. Rising requirements for vaccines, pharmaceutical products, and medical equipment exposed weaknesses in distribution networks and product tracking. Healthcare providers and supply chain participants showed greater interest in digital solutions that support secure information exchange and product authentication. Consequently, blockchain gained attention as a technology for improving medical record management, pharmaceutical traceability, distribution transparency, and coordination during healthcare emergencies.

The cloud-based segment is expected to be the largest during the forecast period

The cloud-based segment is expected to account for the largest market share during the forecast period due to their convenient deployment, operational flexibility, and ability to support expanding healthcare requirements. These platforms enable medical institutions to maintain and share blockchain-protected information without investing heavily in physical infrastructure. Hospitals, drug manufacturers, suppliers, and healthcare professionals can access relevant records across connected networks. Additionally, easier system maintenance, remote accessibility, and compatibility with digital healthcare applications make cloud-based blockchain technology suitable for improving medical information management and pharmaceutical supply chain transparency.

The pharmaceutical companies segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the pharmaceutical companies segment is predicted to witness the highest growth rate as manufacturers increasingly require reliable medicine tracking and authentication systems. Blockchain technology helps pharmaceutical businesses maintain verifiable product records across manufacturing, warehousing, transportation, and distribution activities. It improves visibility into product movements, supports medicine authenticity checks, and strengthens transaction documentation. Increasing attention toward counterfeit drug prevention, regulatory requirements, and secure pharmaceutical distribution is encouraging manufacturers to integrate blockchain platforms into their operations, creating opportunities for wider adoption across pharmaceutical supply chains.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by developed medical infrastructure and widespread adoption of digital healthcare solutions. The region benefits from the presence of pharmaceutical manufacturers, technology companies, and healthcare institutions exploring blockchain applications. In the United States, regulatory initiatives promoting secure pharmaceutical tracking and product verification encourage the development of blockchain-based solutions. Additionally, increasing attention toward patient information protection, healthcare interoperability, and transparent medicine distribution contributes to the expansion of blockchain applications throughout North America.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, supported by expanding digital healthcare infrastructure, pharmaceutical production, and technology investments. Countries including China, India, Japan, and South Korea are increasingly developing advanced healthcare information systems and digital supply chain capabilities. The need for protected patient information, reliable medicine verification, and improved pharmaceutical tracking is creating interest in blockchain applications. Additionally, government-backed healthcare modernization programs and growing technology innovation are encouraging organizations to explore blockchain-based medical record and supply chain solutions.

Key players in the market

Some of the key players in Blockchain for Medical Records & Supply Chain Integrity Market include IBM Corporation, Microsoft Corporation, Oracle Corporation, Guardtime, Patientory Inc., Medicalchain, BurstIQ, Chronicled Inc., Hashed Health, Avaneer Health, Embleema Inc., Blockpharma, Solve.Care, SimplyVital Health, Coral Health, FarmaTrust, MediBloc Inc. and EncrypGen Inc.

Key Developments:

In June 2026, Oracle Health and Theator are working together to provide AI-powered surgical intelligence solutions to Oracle Health customers in the U.S. With Theator's solutions, which capture surgical video footage and use AI to analyze it and cross-reference EHR data, surgical teams can benefit from automated reporting that is more clinically accurate, optimized for billing, and tailored to individual preferences, with no transcription or dictation required.

In December 2025, IBM and Confluent, Inc. announced they have entered into a definitive agreement under which IBM will acquire all of the issued and outstanding common shares of Confluent for $31 per share, representing an enterprise value of $11 billion. Confluent provides a leading open-source enterprise data streaming platform that connects processes and governs reusable and reliable data and events in real time, foundational for the deployment of AI.

In October 2025, Microsoft Corp. on unveiled AI innovations, leveraging ambient and generative technologies, to improve the patient journey, reduce the workflow burden across care teams and enhance the financial integrity of healthcare provider organizations. Microsoft is expanding the capabilities of its leading AI clinical assistant, Dragon Copilot, by introducing the first commercially available ambient experience created for nursing workflows and new extensibility capabilities that allow partners to unlock additional value for Dragon Copilot users.

Components Covered:

• Platforms
• Services

Blockchain Types Covered:

• Public Blockchain
• Private Blockchain
• Consortium & Hybrid Blockchain

Deployment Models Covered:

• On-Premises
• Cloud-Based

Applications Covered:

• Electronic Health Records (EHR) Management
• Clinical Data Exchange & Interoperability
• Pharmaceutical Supply Chain Integrity
• Medical Device Tracking
• Laboratory & Diagnostic Data Security
• Insurance & Claims Management
• Patient Consent & Identity Verification

End Users Covered:

• Hospitals & Clinics
• Pharmaceutical Companies
• Medical Device Manufacturers
• Diagnostic Laboratories
• Insurance Providers
• Government & Regulatory Bodies

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Blockchain for Medical Records & Supply Chain Integrity Market, By Component

• 5.1 Platforms
• 5.2 Services
  • 5.2.1 Consulting
  • 5.2.2 Integration & Deployment
  • 5.2.3 Support & Maintenance

6 Global Blockchain for Medical Records & Supply Chain Integrity Market, By Blockchain Type

• 6.1 Public Blockchain
• 6.2 Private Blockchain
• 6.3 Consortium & Hybrid Blockchain

7 Global Blockchain for Medical Records & Supply Chain Integrity Market, By Deployment Model

• 7.1 On-Premises
• 7.2 Cloud-Based

8 Global Blockchain for Medical Records & Supply Chain Integrity Market, By Application

• 8.1 Electronic Health Records (EHR) Management
• 8.2 Clinical Data Exchange & Interoperability
• 8.3 Pharmaceutical Supply Chain Integrity
• 8.4 Medical Device Tracking
• 8.5 Laboratory & Diagnostic Data Security
• 8.6 Insurance & Claims Management
• 8.7 Patient Consent & Identity Verification

9 Global Blockchain for Medical Records & Supply Chain Integrity Market, By End User

• 9.1 Hospitals & Clinics
• 9.2 Pharmaceutical Companies
• 9.3 Medical Device Manufacturers
• 9.4 Diagnostic Laboratories
• 9.5 Insurance Providers
• 9.6 Government & Regulatory Bodies

10 Global Blockchain for Medical Records & Supply Chain Integrity Market, By Geography

• 10.1 North America
  • 10.1.1 United States
  • 10.1.2 Canada
  • 10.1.3 Mexico
• 10.2 Europe
  • 10.2.1 United Kingdom
  • 10.2.2 Germany
  • 10.2.3 France
  • 10.2.4 Italy
  • 10.2.5 Spain
  • 10.2.6 Netherlands
  • 10.2.7 Belgium
  • 10.2.8 Sweden
  • 10.2.9 Switzerland
  • 10.2.10 Poland
  • 10.2.11 Rest of Europe
• 10.3 Asia Pacific
  • 10.3.1 China
  • 10.3.2 Japan
  • 10.3.3 India
  • 10.3.4 South Korea
  • 10.3.5 Australia
  • 10.3.6 Indonesia
  • 10.3.7 Thailand
  • 10.3.8 Malaysia
  • 10.3.9 Singapore
  • 10.3.10 Vietnam
  • 10.3.11 Rest of Asia Pacific
• 10.4 South America
  • 10.4.1 Brazil
  • 10.4.2 Argentina
  • 10.4.3 Colombia
  • 10.4.4 Chile
  • 10.4.5 Peru
  • 10.4.6 Rest of South America
• 10.5 Rest of the World (RoW)
  • 10.5.1 Middle East
    • 10.5.1.1 Saudi Arabia
    • 10.5.1.2 United Arab Emirates
    • 10.5.1.3 Qatar
    • 10.5.1.4 Israel
    • 10.5.1.5 Rest of Middle East
  • 10.5.2 Africa
    • 10.5.2.1 South Africa
    • 10.5.2.2 Egypt
    • 10.5.2.3 Morocco
    • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

• 11.1 Industry Value Network and Supply Chain Assessment
• 11.2 White-Space and Opportunity Mapping
• 11.3 Product Evolution and Market Life Cycle Analysis
• 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

• 12.1 Mergers and Acquisitions
• 12.2 Partnerships, Alliances, and Joint Ventures
• 12.3 New Product Launches and Certifications
• 12.4 Capacity Expansion and Investments
• 12.5 Other Strategic Initiatives

13 Company Profiles

• 13.1 IBM Corporation
• 13.2 Microsoft Corporation
• 13.3 Oracle Corporation
• 13.4 Guardtime
• 13.5 Patientory Inc.
• 13.6 Medicalchain
• 13.7 BurstIQ
• 13.8 Chronicled Inc.
• 13.9 Hashed Health
• 13.10 Avaneer Health
• 13.11 Embleema Inc.
• 13.12 Blockpharma
• 13.13 Solve.Care
• 13.14 SimplyVital Health
• 13.15 Coral Health
• 13.16 FarmaTrust
• 13.17 MediBloc Inc.
• 13.18 EncrypGen Inc.